Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation
Chemical Engineering Journal · 2026-07 · 540 · 177487
DOI: 10.1016/j.cej.2026.177487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-07. Verfasst von Ying Wang und 10 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Xiong, W., Xu, Y., Yang, N., Zheng, H., Zhao, Q., Liang, X., Yin, H., Zhang, Y., Zhou, W., & Fan, L. (2026). Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation. Chemical Engineering Journal, 540, 177487. https://doi.org/10.1016/j.cej.2026.177487
Vancouver
Wang Y, Xiong W, Xu Y, Yang N, Zheng H, Zhao Q, et al. Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation. Chemical Engineering Journal. 2026;540:177487. doi:10.1016/j.cej.2026.177487
BibTeX
@article{Wang2026,
author = {Wang, Ying and Xiong, Wanying and Xu, Yiyan and Yang, Nan and Zheng, Huige and Zhao, Qian and Liang, Xiaojing and Yin, Huishuang and Zhang, Yunyan and Zhou, Wenhu and Fan, Liangsheng},
title = {Nano-immunotherapy combining PD-L1 blockade with Ca2+-mediated immune activation},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {540},
pages = {177487},
doi = {10.1016/j.cej.2026.177487}
}
EUVIMED